Eric Sievers
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Eric Sievers
BioAtla, Inc. reported in an 8-K filed September 29, 2026 that Eric Sievers resigned as Chief Medical Officer, effective September 25, 2026. The proxy statement of BioAtla, Inc. reports total compensation of $584,408 for Eric Sievers in fiscal 2025, including a base salary of $530,630. Disclosed compensation is on record for 5 fiscal years. Eric Sievers has spoken on 6 earnings calls across 1 company, most recently for BioAtla, Inc. on November 13, 2025.
“On September 25, 2026, Dr. Eric Sievers resigned from his position as the Company’s Chief Medical Officer to pursue interests outside of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
BioAtla, Inc. (BCAB)
Proxy statement
Start not stated–2026-09-25
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | BioAtla, Inc. (BCAB) | Chief Medical Officer | $530,630 | $584,408 |
| 2024 | BioAtla, Inc. (BCAB) | Chief Medical Officer | $510,220 | $961,075 |
| 2023 | BioAtla, Inc. (BCAB) | Chief Medical Officer | $470,250 | $1,316,844 |
| 2022 | BioAtla, Inc. (BCAB) | Chief Medical Officer | $446,160 | $1,153,473 |
| 2021 | BioAtla, Inc. (BCAB) | Chief Medical Officer | $405,600 | $552,616 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.